Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07253987

Cancer Survivors Program

Led by Masaryk Memorial Cancer Institute · Updated on 2026-04-17

200

Participants Needed

1

Research Sites

86 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.

CONDITIONS

Official Title

Cancer Survivors Program

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • The patient understands the information provided and agrees to participate in the study.
  • Age 18 years or older.
  • Histologically confirmed invasive breast cancer or invasive prostate cancer.
  • Completion of the acute phase of curative oncological therapy: for breast cancer, curative surgery performed plus completed neoadjuvant/adjuvant chemotherapy and completed adjuvant radiotherapy if indicated; for prostate cancer, completed radiotherapy with curative intent or radical prostatectomy performed (open, laparoscopic, robotic) or completed adjuvant radiotherapy after prostatectomy.
  • The patient is available for follow-up within 12 months of enrollment in the study.
Not Eligible

You will not qualify if you...

  • Active ongoing oncological therapy except for adjuvant hormone therapy, adjuvant targeted therapy (anti-HER2 therapy, CDK4/6i, PARPi, T-DM1), or adjuvant immunotherapy.
  • Neoadjuvant/adjuvant therapy did not include chemotherapy for breast cancer.
  • Recurrence of cancer.
  • Metastatic disease.
  • History of other primary malignancy except for non-melanoma skin cancer.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Masaryk Memorial Cancer Institute

Brno, Czechia, 656 53

Actively Recruiting

Loading map...

Research Team

L

Lenka Pavčíková, MUDr.

CONTACT

M

Martina Lojová, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Cancer Survivors Program | DecenTrialz